Elevate Program

Cardiomyopathies and the Artificial Heart Transplant

Heart disease is the leading cause of death in Australia. In this webinar, GPs will hear about a new breakthrough in heart technology that will change the future of heart health in Australia, as well as practical evidence based surgical and non-surgical options for managing heart disease.

RACGP: 1hr EA hour CONTENT: 1 Video (1hr)

Evaluation Form

Learning Outcomes

Identify the evidence-based management options for patients with mild aortic stenosis or mitral valve
regurgitation who are under long-term cardiology care.
Identify the evidence-based surgical and non-surgical management options for patients with Atrial Fibrillation and Arrythmias.
Identify the evidence-based surgical and non-surgical management options for patients with Congestive Cardiac Failure.

Claim your CPD hours

Thank you for watching our content. Please complete the
evaluation form in order to receive your CPD hours.

Evaluation Form

Cardiomyopathies and the Artificial Heart Transplant

.a { fill: none; stroke: #fff; stroke-linejoin: round; stroke-width: 2px; } Elevate Program

Cardiomyopathies and the Artificial Heart Transplant